cro.directory
← Compare landing

ADViRNA vs TATAA Biocenter

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryADViRNATATAA Biocenter
SummaryADViRNA provides oligonucleotide design, synthesis, and screening services with proprietary chemical modifications and conjugation technologies for therapeutic siRNA and ASO development.GLP- and GCLP-compliant molecular CRO specializing in bioanalysis for gene therapy, RNA therapeutics, and advanced modalities, offering qPCR, NGS, and plasma proteomics services since 2001.
Services
  • Translational Research
  • Bioconjugation Services
  • Oligonucleotide Manufacturing
  • CMC Analytical Development
  • Bioanalysis
  • Biomarker Assays
  • Translational Research
  • Genomics & Sequencing Services
  • Proteomics Services
Modalities
  • Oligonucleotide
  • Oligonucleotide
  • mRNA
  • Cell Therapy
  • Gene Therapy
IndicationsData not yet provided.Data not yet provided.
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (General)
  • Phase I
  • Phase II
  • Phase III
Sourcing models
  • Functional Service Provider (FSP)
  • Full-Service Outsourcing (FSO)
LocationsData not yet provided.
  • Headquarters, Gothenburg, Västra Götaland, Sweden
CertificationsData not yet provided.
  • SWEDAC · Identifier: GLP-accredited for qPCR, dPCR, and molecular biology
  • ISO/IEC · Identifier: ISO/IEC 17025-compliant

Find similar companies

ADViRNA alternatives · TATAA Biocenter alternatives

Markdown mirror: /compare/advirna/tataa-biocenter.md